Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First in Man Study of the JenaValve TAVI Plus System Transfemoral

NCT02818959 is registered in ClinicalTrials.gov with JenaValve Technology, Inc. as lead sponsor.

NCT NCT02818959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02818959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First in Man Study of the JenaValve TAVI Plus System Transfemoral
Lead sponsor
JenaValve Technology, Inc.
Phase
Not applicable
Overall status
Terminated
Start date
December 31, 2013
Completion date
May 31, 2015
Enrollment
7 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve stenosis, cardiovascular diseases, heart diseases, heart valve diseases